Clinical Trial

A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Study acronym: CKD-706
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a randomised, double-blind, three-arm, parallel group, single-dose, Phase 1 comparative study of CKD-706, US-Dupixent, and EU-Dupixent in healthy adult participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-14.
Trial Details
NCT Number NCT07358156
Lead Sponsor Chong Kun Dang Pharmaceutical
Collaborators: Parexel
Conditions Atopic Dermatitis
Enrollment 519 participants
Start Date 2026-02-09
Primary Completion 2026-11-16 (estimated)
Study Completion 2026-11-16 (estimated)
Updated on ClinicalTrials.gov 2026-01-23